| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.48▲ | 4.44▲ | 4.43▲ | 4.34▲ | 4.21▲ |
| MA10 | 4.43▲ | 4.38▲ | 4.38▲ | 4.40▲ | 4.10▲ |
| MA20 | 4.38▲ | 4.33▲ | 4.35▲ | 4.21▲ | 3.46▲ |
| MA50 | 4.38▲ | 4.37▲ | 4.30▲ | 4.03▲ | 2.46▲ |
| MA100 | 4.40▲ | 4.20▲ | 4.14▲ | 3.41▲ | 2.58▲ |
| MA200 | 4.21▲ | 4.01▲ | 4.02▲ | 2.58▲ | 4.03▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | 0.020▲ | 0.012▲ | 0.004▲ | 0.043▲ |
| RSI | 57.671▲ | 56.929▲ | 57.686▲ | 57.683▲ | 65.723▲ |
| STOCH | 90.856▲ | 78.772 | 72.278 | 49.712 | 48.506 |
| WILL %R | -8.696▲ | -7.407▲ | -6.061▲ | -39.423 | -78.360▼ |
| CCI | 103.056▲ | 138.804▲ | 136.160▲ | 46.718 | 28.065 |
| MA | $NERV Price Crossed Above MA(7) | Set Alert |
|
Saturday, December 06, 2025 10:52 AM
The average one-year price target for Minerva Neurosciences (NasdaqCM:NERV) has been revised to $4.59 / share. This is an increase of 12.50% from the prior estimate of $4.08 dated November 14, 2025.
|
|
Tuesday, November 04, 2025 11:30 PM
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/01/26 | 4.36 | 4.51 | 4.21 | 4.45 | 34,840 |
| 15/01/26 | 4.31 | 4.535 | 4.1401 | 4.33 | 92,051 |
| 14/01/26 | 4.27 | 4.395 | 4.10 | 4.31 | 50,500 |
| 13/01/26 | 4.31 | 4.31 | 4.081 | 4.27 | 16,900 |
| 12/01/26 | 4.45 | 4.51 | 3.96 | 4.32 | 70,000 |
| 09/01/26 | 4.75 | 4.75 | 4.38 | 4.45 | 52,000 |
| 08/01/26 | 4.77 | 4.77 | 4.53 | 4.70 | 63,100 |
| 07/01/26 | 4.25 | 4.86 | 4.25 | 4.71 | 187,900 |
| 06/01/26 | 4.07 | 4.44 | 4.05 | 4.32 | 138,600 |
| 05/01/26 | 3.96 | 4.20 | 3.90 | 4.15 | 65,500 |
|
|
||||
|
|
||||
|
|